Learn the latest changes to reporting products and procedures related to Chimeric Antigen Receptor T-cell therapy to ensure proper coding. Expensive cutting-edge cancer therapy is available to Medicare patients nationwide. Back in 2019, the Centers for Medicare & Medicaid Services (CMS) finalized the long-sought rules for coverage of chimeric antigen receptor (CAR) T-cell therapy, a […]
The post CAR-T Reimbursement Requirements Revamped Again appeared first on AAPC Knowledge Center.